Legal Affairs
Innocan Pharma Closes Additional Insider Debenture
HERZLIYA-CALGARY – Innocan Pharma Corp. announced that it had completed the closing of an additional secured debenture with its largest shareholder, Tamar Innovest Ltd., for gross proceeds of $200,000. The financing follows the company’s earlier ...
New Mexico Allocates $630K for Medical Psilocybin Treatment Equity Fund
SANTA FE – Gov. Michelle Lujan Grisham signed the state’s annual budget bill, setting aside $630,000 to create the Medical Psilocybin Treatment Equity Fund and extend access to supervised psilocybin therapy for low-income and rural ...
Vireo Growth and MWBE-Led Ace Venture Announce Strategic Partnership
NEW YORK – Vireo Growth Inc. has struck a deal with minority and women-owned business enterprise (MWBE) of Ace Venture of NY to hand over controlling ownership of its long-running medical Cannabis operations in the ...
What’s it Like Being a Black Entrepreneur in Cannabis?
COLUMBUS, OHIO- Although I was born and raised in Cleveland, my journey as a black entrepreneur in Cannabis didn’t start in a dispensary or at a grow facility. It actually started in culture, in music. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – It's been another fortnight, and the numbers, the deals, and the science keep telling the same story: the Cannabis & Psychedelics space is not slowing down. A few from the MSOs pack ...
Trulieve Reports Q4 and FY 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp., the largest U.S. Cannabis retailer by store count, announced its full-year 2025 revenue of $1.2 billion, holding steady from the previous year as retail pricing pressures offset gains from new ...
Curaleaf Reports Q4 and FY 2025 Financial Results
NEW YORK – Curaleaf Holdings Inc. released its earnings for the fourth quarter and full year ended December 31, 2025, highlighting a return to top-line growth and steady margins in a tough domestic environment. The ...
Innocan Pharma Closes Additional Insider Debenture
HERZLIYA-CALGARY – Innocan Pharma Corp. announced that it had completed the closing of an additional secured debenture with its largest shareholder, Tamar Innovest Ltd., for gross proceeds of $200,000. The financing follows the company’s earlier ...
New Mexico Allocates $630K for Medical Psilocybin Treatment Equity Fund
SANTA FE – Gov. Michelle Lujan Grisham signed the state’s annual budget bill, setting aside $630,000 to create the Medical Psilocybin Treatment Equity Fund and extend access to supervised psilocybin therapy for low-income and rural ...
Vireo Growth and MWBE-Led Ace Venture Announce Strategic Partnership
NEW YORK – Vireo Growth Inc. has struck a deal with minority and women-owned business enterprise (MWBE) of Ace Venture of NY to hand over controlling ownership of its long-running medical Cannabis operations in the ...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results
LOS ANGELES- Numinus Wellness Inc. has announced its financial results for the fourth quarter and the full year of fiscal 2023, highlighting significant revenue growth and strategic advancements in its operations. Fourth Quarter Fiscal 2023 ...
New York Cannabis Control Board Approves Settlement
NEW YORK- In a pivotal decision this week, the New York Cannabis Control Board resolved a lawsuit brought by military veterans, unlocking the way for over 400 adult-use cannabis dispensaries to progress in the state. ...
California and Michigan Boost Social Equity in Cannabis Industry with New Funding Initiatives
LOS ANGELES- In a significant move to bolster social equity within the cannabis industry, both California and Michigan have recently taken steps to channel more funding into social equity cannabis companies. California is set to ...
Clearmind Medicine Inc Reports Promising Results in Pre-Clinical Trial for Combination Therapy
LOS ANGELES- Clearmind Medicine Inc has announced the results of its pre-clinical trial involving a combination therapy, marking a significant step in the development of treatments for addictions, obesity, metabolic disorders, and depression. The trial ...
RIV Capital’s Ambitious Transition to Adult-Use Cannabis Sales in New York
LOS ANGELES- RIV Capital, a Toronto-based cannabis investment firm, has navigated a turbulent path in its growth story, particularly in the New York market. Initially setting up as one of the few medical cannabis operators ...
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...
Record Sales on Green Wednesday Signal Booming Cannabis Market
LOS ANGELES- The cannabis industry experienced a significant surge in sales on Green Wednesday, the day before Thanksgiving, marking it as a high-point in annual cannabis commerce. Jane Technologies reported recreational cannabis sales totaling an ...
Arkansas and Rhode Island Cannabis Markets
LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...
Wisconsin Legislators Advocate for Veterans’ Access to Psilocybin Therapy Amid National Psychedelic Research Surge
LOS ANGELES- In a groundbreaking move, Wisconsin lawmakers are pushing for enhanced access to psilocybin, a psychedelic compound found in magic mushrooms, for military veterans suffering from post-traumatic stress disorder (PTSD). This bipartisan bill represents ...
Irwin Naturals Inc. Reports Financial Performance in Q3 2023
LOS ANGELES- Irwin Naturals Inc, a key player in the cannabis and mental health sectors, recently disclosed its financial results for the third quarter of fiscal 2023, ending September 30, 2023. The report presents a complex ...
Maryland Supreme Court Refuses to Review Injunction on Anti-Intoxicating Hemp Law
LOS ANGELES- The Maryland Supreme Court has recently opted not to review a lower court's injunction against the enforcement of the state's law aimed at banning intoxicating hemp products. This decision, as detailed in a ...
Georgia Advances Medical Cannabis Program After Legal Delays
LOS ANGELES' In a significant development for Georgia's medical cannabis sector, state regulators have resumed the licensing process, concluding a prolonged two-year legal standoff. This move, as reported by the Valdosta Daily Times, comes after ...
Algernon Pharmaceuticals Partners with Seyltx Inc.
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a significant advancement in its research program. The company has signed a Letter of Intent (LOI) with Seyltx Inc., a U.S.-based ...
Psychedelic Therapy for PTSD: Veterans Seek Healing in Mexico Amid U.S. Legal Restrictions
LOS ANGELES- A recent CBS News report has brought to light a significant trend among veterans dealing with PTSD: an increasing number are seeking psychedelic-assisted treatments in Mexico, utilizing substances currently deemed illegal by the ...
Optimi Health Obtains Key Amendment to Dealer’s Licence
LOS ANGELES- Optimi Health, a Canadian company specializing in psychedelic drug research and formulation, has achieved a significant milestone with Health Canada's approval of an amendment to its Dealer's Licence. This crucial development allows Optimi ...
Germany Amends Cannabis Legalization Bill, Balancing Reform and Regulation
BERLIN- German lawmakers have significantly revised the country's cannabis legalization bill, incorporating feedback from cannabis reform advocates and aiming for the bill's enactment in the upcoming spring. This development, as reported by Marijuana Moment, ...
Psyence Group Inc. Announces Resignation of Board Member Marvin Singer
LOS ANGELES- Psyence Group Inc a clinical-stage life science biotechnology firm at the forefront of utilizing nature-derived psilocybin for mental health and wellbeing, today announced the resignation of Mr. Marvin Singer from his role as ...
Compass Pathways Launches UK Phase of Landmark Psilocybin Study for Treatment-Resistant Depression
NEW YORK- Compass Pathways plc (Nasdaq: CMPS), a biotechnology leader dedicated to advancing mental health treatments, has announced the initiation of the UK component of its phase 3 program investigating COMP360 psilocybin treatment for treatment-resistant ...
Alabama Medical Cannabis Commission Settles Lawsuits
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has made significant strides this week by reaching a settlement with license applicants, a move aimed at resolving the multiple lawsuits filed against the agency. This development, ...
Swedish Researchers Use Psychedelics to Explore Brain Function and AI Development
LOS ANGELES- In a groundbreaking study at Lund University in Sweden, researchers are employing psychedelic substances, specifically acid (LSD) and ketamine, to delve into the intricate workings of the brain. This unique approach aims to ...
Minnesota Tests New Saliva-Based Roadside Cannabis Impairment Assessment
LOS ANGELES- In a groundbreaking move, Minnesota's Office of Traffic Safety (OTS) has initiated a pilot program to test a saliva-based roadside cannabis impairment test. This innovative approach is designed to enhance the state's capabilities ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis dispensaries have achieved over $100 million in adult-use sales, ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development of innovative psychedelic treatments. The company announced the closure ...
Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq Regulations
NEW YORK- Clearmind Medicine Inc., a biotech company renowned for its innovative work in developing psychedelic-derived therapeutics, has announced a strategic decision to conduct a reverse share split of its ordinary shares. This move is ...
Revive Therapeutics Advances Development of Innovative Bucillamine Formulation for Medical Emergencies
LOS ANGELES- Revive Therapeutics Ltd, a specialty life sciences company, has recently announced significant progress in the development of a new lyophilized formulation of Bucillamine, a drug initially designed for medical needs and rare disorders. ...
